LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 19.69 | 84.90 | 821 | 1239 | 0.6624 | 0.7980 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 19.69 | 84.90 | 936 | 1239 | 0.7552 | 0.8600 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 19.69 | 84.90 | 991 | 1239 | 0.7996 | 0.8876 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 19.69 | 84.90 | 1253 | 1239 | 1.0109 | 1.0056 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 21.40 | 84.90 | 848 | 1454 | 0.5830 | 0.7533 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 21.40 | 84.90 | 919 | 1454 | 0.6318 | 0.7880 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 21.40 | 84.90 | 1022 | 1454 | 0.7026 | 0.8350 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 21.40 | 84.90 | 1200 | 1454 | 0.8249 | 0.9083 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 23.10 | 84.90 | 917 | 1616 | 0.5674 | 0.7504 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 23.10 | 84.90 | 974 | 1616 | 0.6026 | 0.7754 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 23.10 | 84.90 | 1076 | 1616 | 0.6658 | 0.8175 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 23.10 | 84.90 | 1269 | 1616 | 0.7852 | 0.8894 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 24.81 | 84.90 | 932 | 1769 | 0.5267 | 0.7278 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 24.81 | 84.90 | 980 | 1769 | 0.5538 | 0.7477 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 24.81 | 84.90 | 1144 | 1769 | 0.6465 | 0.8105 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 24.81 | 84.90 | 1291 | 1769 | 0.7296 | 0.8611 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 26.51 | 84.90 | 900 | 1923 | 0.4680 | 0.6896 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 26.51 | 84.90 | 936 | 1923 | 0.4867 | 0.7043 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 26.51 | 84.90 | 1228 | 1923 | 0.6385 | 0.8103 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 26.51 | 84.90 | 1346 | 1923 | 0.6999 | 0.8476 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 28.21 | 84.90 | 936 | 2091 | 0.4475 | 0.6807 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 28.21 | 84.90 | 971 | 2091 | 0.4643 | 0.6941 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 28.21 | 84.90 | 1178 | 2091 | 0.5632 | 0.7664 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 28.21 | 84.90 | 1275 | 2091 | 0.6096 | 0.7969 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 29.92 | 84.90 | 872 | 2237 | 0.3897 | 0.6380 | MN20160318_Q02 | F03 |